12 patients (34.28%) dropped out side effects. These data differ slightly with the findings of an earlier open-label 52-week study (Wohlreich et al., 2004),
12 patients (34.28%) dropped out side effects. These data differ slightly with the findings of an earlier open-label 52-week study (Wohlreich et al., 2004),